Paras Biopharmaceuticals Finland Oy is established and development work takes off with Diabrid Technology Platform.
Technology skills and biopharmaceuticals capabilities realized. Work initiated on Diabrid Technology Platform.
Paras Biopharmaceuticals Finland Oy is conceptualized; details finalized.
Company's executives formally meet and decide on the roadmap for the next 10-20 years.
This website uses cookies; by continuing to use this page, you consent to their use. I Understand About Cookies.
